Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Should You Keep an Eye on These Eye Treatment Biotechs?
Should You Keep an Eye on These Eye Treatment Biotechs?
Should You Keep an Eye on These Eye Treatment Biotechs?
Submitted by
admin
on August 9, 2013 - 10:30am
Source:
Motley Fool
News Tags:
wet age-related macular degeneration
diabetic macular edema
Lucentis
Novartis
Roche
Eylea
Regeneron
Optina
Ampio Pharmaceuticals
Headline:
Should You Keep an Eye on These Eye Treatment Biotechs?
Do Not Allow Advertisers to Use My Personal information
